EBITDA

M Health Fairview adopts Nabla's AI to combat doctor burnout, aiming to free clinicians from screens and bring the focus back to patient care.

A landmark deal sees US tech giant CrowdStrike partner with Aramco to build a national cybersecurity defense, securing Saudi Arabia's AI-driven future.

With backing from top VCs, Angitia Biopharmaceuticals is accelerating its novel treatments for osteoporosis and rare bone disorders. Here's why it matters.

Nullify lands $12.5M to deploy autonomous AI security engineers, aiming to solve the cyber talent gap by replacing manual work with merge-ready code.

WealthTech firm BizEquity targets the Great Wealth Transfer with a new brand and AI-powered platform to help advisors value and plan for business owner clients.

Main Street Capital and Iron Creek Partners facilitate a buyout of BASELoad, LLC, a key player in healthcare data, signaling a strategic push into this vital sector.

Pluristyx and Solesis launch a 'three-in-one' kit with nearly 100% efficiency in iPSC transfection, tackling a major bottleneck in organoid research.

Pilot Fiber's acquisition of Extenet's enterprise fiber business expands its reach into NJ, targeting the high-stakes finance and AI sectors.

A new study reveals Exicure's burixafor mobilizes stem cells in one hour, promising to streamline cancer treatment and unlock future gene therapies.

The multiyear agreement makes Baker Hughes the preferred tech provider for Marathon's vast network of oil and renewable fuels facilities across North America.

New data reveals an AI-powered system can map and guide heart arrhythmia treatment in minutes with zero fluoroscopy, heralding a new era of safety and speed.

After conquering the US, the AI finance app is back on home turf. But can its playful 'roast mode' succeed in a crowded British FinTech market?

A renewed partnership extends into a third decade, leveraging advanced logistics to build the Royal Navy's new Type 26 frigates and validating a key acquisition.

Kling AI's new 3.0 models promise photorealistic video with unprecedented consistency, challenging rivals and reshaping creative industries.

The South Korean tobacco giant hits record revenue as its international strategy pays off, while it diversifies into nicotine pouches for future growth.

Volvo Cars' Q4 profits fell, but a tough cost-cutting plan boosted cash flow, setting the stage for its critical electric vehicle push in a tough market.

Forgent Power Solutions prices its IPO at $27 a share, targeting a massive valuation fueled by intense demand from data centers and grid modernization.

Futures designer Nick Foster joins Unlikely Collaborators to challenge prediction, urging us to examine the hidden biases that shape what we see as possible.

Everest Medicines bets big on MT1013, a novel dual-action drug poised to transform treatment for millions with chronic kidney disease complications.

The semiconductor giant posted a huge Non-GAAP profit but a stunning IFRS loss for 2025. What's behind the numbers and why are investors cheering?